Summit Therapeutics Inc.
NasdaqGM:SMMT
Sector
Industries
Location
Market Cap
USD 19.08 B
Share Price
USD 25.68
Avg Daily Volume
3,784,530
Change (1 day)
-9.08%
Change (1 year)
133.93%
Change (YTD)
43.89%
Summit Therapeutics Inc. Accounts Payable for the year ending December 31, 2021: USD 4.37 M
Summit Therapeutics Inc. Accounts Payable is USD 4.37 M for the year ending December 31, 2021, a -28.76% change year over year. Accounts payable are amounts owed by the company to suppliers or vendors for goods or services received but not yet paid.
-
Summit Therapeutics Inc. Accounts Payable for the year ending December 31, 2020 was USD 6.14 M.
-
Summit Therapeutics Inc. Accounts Payable for the year ending January 31, 2019 was USD 15.24 M, a -15.05% change year over year.
-
Summit Therapeutics Inc. Accounts Payable for the year ending January 31, 2018 was USD 17.94 M.
StockViz
Competitors
Eli Lilly and Company
USD 639.43
LLY
+4.21
0.66%
AbbVie Inc.
USD 198.64
ABBV
-0.06
-0.03%
Roche Holding AG
USD 320.12
RO.SW
+2.62
0.83%
AstraZeneca PLC
USD 150.15
AZN.L
-2.01
-1.32%
Novartis AG
USD 119.03
NOVN.SW
+1.05
0.89%
Novo Nordisk A/S
USD 50.00
NOVO-B.CO
-0.09
-0.18%
Merck & Co., Inc.
USD 80.30
MRK
+0.27
0.34%
Thermo Fisher Scientific Inc.
USD 477.41
TMO
+15.02
3.25%
Amgen Inc.
USD 284.98
AMGN
-0.11
-0.04%
Gilead Sciences, Inc.
USD 120.02
GILD
-0.45
-0.37%
Pfizer Inc.
USD 24.65
PFE
+0.07
0.29%
Sanofi
USD 95.31
SAN.PA
+0.83
0.88%
Vertex Pharmaceuticals Incorporated
USD 387.77
VRTX
+13.31
3.55%
Bristol-Myers Squibb Company
USD 46.55
BMY
+0.62
1.35%
Chugai Pharmaceutical Co., Ltd.
USD 42.73
4519.T
+0.95
2.28%
Key Data
| Date | Accounts Payable | Short-Term Debt | Long-Term Debt | Total Liabilities |
|---|
Competitors
Eli Lilly and Company
USD 639.43
LLY
+4.21
0.66%
AbbVie Inc.
USD 198.64
ABBV
-0.06
-0.03%
Roche Holding AG
USD 320.12
RO.SW
+2.62
0.83%
AstraZeneca PLC
USD 150.15
AZN.L
-2.01
-1.32%
Novartis AG
USD 119.03
NOVN.SW
+1.05
0.89%
Novo Nordisk A/S
USD 50.00
NOVO-B.CO
-0.09
-0.18%
Merck & Co., Inc.
USD 80.30
MRK
+0.27
0.34%
Thermo Fisher Scientific Inc.
USD 477.41
TMO
+15.02
3.25%
Amgen Inc.
USD 284.98
AMGN
-0.11
-0.04%
Gilead Sciences, Inc.
USD 120.02
GILD
-0.45
-0.37%
Pfizer Inc.
USD 24.65
PFE
+0.07
0.29%
Sanofi
USD 95.31
SAN.PA
+0.83
0.88%
Vertex Pharmaceuticals Incorporated
USD 387.77
VRTX
+13.31
3.55%
Bristol-Myers Squibb Company
USD 46.55
BMY
+0.62
1.35%
Chugai Pharmaceutical Co., Ltd.
USD 42.73
4519.T
+0.95
2.28%